Glycine-BIO Pharmaplant®

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.29.003.Е.001578.02.15
Date of registration and renewal:02.02.2015
Dosage form: & nbspTablets weighing 0.11 g - glycine 100 mg; tablets weighing 0.25 g - glycine 200 mg; tablets weighing 0.4 g - glycine 300 mg; tablets weighing 1.0 g - glycine 600 mg.
Classification "Composition" & nbsp Other dietary supplements
Composition: & nbspGlycine, lactose, PVP, calcium stearate.
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, departments of the trade network as a biologically active food additive - glycine source.
Suggested Usage: & nbspAdults and children over 14 years of age - glycine 100 mg - 2 tablets 3 times a day, or glycine 200 mg - 1 tablet 3 times a day, or glycine 300 mg - 1 tablet 2 times a day, or glycine 600 mg - 1 tablet a day immediately after meals sublingually (keep the tablet under the tongue until completely dissolved). Duration of admission is 1 month. Reception can be repeated 3-4 times a year.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.11.003.E.016538.11.12 dated 11/23/2012, the expert conclusion of the FBU of the Federal Target Program and the Federal Service for Supervision of Consumer Rights Protection No. 10-2FTS / 4023 dated 27.09.2012, the protocol of the AILTS FBU "FTSGiE" of Rospotrebnadzor No. № 1690, 1691 of 15.01.2015.
Recipient:Pharmaplant Fabrication Chemiste Product GmbHPharmaplant Fabrication Chemiste Product GmbH Germany
Information update date: & nbsp08.03.2017
Instructions
Up